Search Results 211-220 of 17336 for Teratogenic

1. A Study to Evaluate Prevention of Paclitaxel-Associated Neuropathy with Fingolimod - Mayo Clinic

   Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons;; Nursing persons ...

2. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

   ... teratogenic effects; Nursing women; Men or women of childbearing potential who are unwilling to employ adequate contraception throughout the study and for 8 ...

3. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   ... teratogenic effects on the developing fetus and newborn are unknown * Pregnant women * Nursing women * Men or women of childbearing potential who are ...

4. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

5. A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca - Mayo Clinic

   Participation eligibility · Any of the following because this study involves therapy that has known genotoxic, mutagenic and teratogenic effects: · Neoadjuvant ...

6. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

   Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons;; Nursing persons ...

7. Congenital Clinical Trials - Mayo Clinic Research

   Additionally, to perform RNA Sequencing and targeted metabolomics analysis to identify alterations in gene expression and metabolites associated with the NAD ...

8. A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia - Mayo Clinic

   The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...

9. CSF1R And TAM Receptor Inhibition With Q702 - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effect on the developing fetus and newborn ...

10. Venetoclax In Combination With ASTX727 For The Treatment Of Chronic Myelomonocytic Leukemia And Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm - Mayo Clinic

    potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for adverse events in nursing infants secondary to ...